Try our Advanced Search for more refined results
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Case Number:
1:19-md-02875
Court:
Nature of Suit:
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Ahmuty Demers
- Baker Donelson
- Baker & Hostetler
- Barnes & Thornburg
- Beasley Allen
- Beasley Firm
- Benesch
- Buchanan Ingersoll
- Bursor & Fisher
- Chaffin Luhana LLP
- Cipriani & Werner
- Cohen Placitella
- Crowell & Moring
- Davis & Crump
- Donahey Law
- Douglas & London
- Duane Morris
- Eimer Stahl
- Eisenberg Rothweiler
- Erlanger Law Firm
- Fears Nachawati
- Gainey McKenna
- Golomb Spirt
- Grant & Eisenhofer
- Greenberg Traurig
- Guerra LLP
- Hardin Kundla
- Hill Wallack
- Hinshaw & Culbertson
- Hofeld & Schaffner
- Husch Blackwell
- Kanner & Whiteley
- Kirkland & Ellis
- Krivit Law
- Labaton Keller
- Law Office of Adam R. Gonnelli
- Law Office of Barry R. Glazer
- Lewis Brisbois
- Lowey Dannenberg
- Marshall Dennehey
- Mazie Slater
- Messa & Associates
- Miller Shah LLP
- Morgan Lewis
- Murphy & Dunn
- Nagel Rice
- Napoli Shkolnik
- ND Galli Law LLC
- Novitzke Gust
- Oliver Law Group PC
- Parafinczuk Wolf
- Pietragallo Gordon
- Polsinelli PC
- Powell Kugelman
- Rawle & Henderson
- Rheingold Giuffra
- Rueb Stoller
- Saul Ewing
- Sills Cummis
- Skadden Arps
- Stark & Stark
- Sullivan Papain
- Troutman Pepper
- Walsh Pizzi
- Wheeler Trigg
- Wong Fleming
- Wood Smith
- Zareh & Associates
- Zoll & Kranz
Companies
- Albertsons Cos. Inc.
- Allergan PLC
- Amneal Pharmaceuticals Inc.
- A-S Medication Solutions LLC
- Aurobindo Pharma Ltd.
- Avkare Inc.
- Camber Pharmaceuticals Inc.
- Cardinal Health Inc.
- Cencora Inc.
- CVS Health Corp.
- Express Scripts Holding Co.
- GSMS Inc.
- Harris Teeter Supermarkets, Inc.
- Hetero Drugs Ltd.
- Humana Inc.
- Hy-Vee
- Jubilant Cadista
- LifeWallet
- McKesson Corp.
- Mylan NV
- NuCare Pharmaceuticals Inc.
- Optum Inc.
- OptumRx Inc.
- Prime Therapeutics LLC
- Prinston Pharmaceutical Inc.
- Red Oak Sourcing LLC
- Rite Aid Corp.
- ScieGen Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
- The Cigna Group
- The Harvard Drug Group LLC
- The Kroger Co.
- The Linde Group
- Torrent Pharmaceuticals Ltd.
- Village Super Market Inc.
- Walgreens Boots Alliance Inc.
- Walmart Inc.
- Weis Markets Inc.
Sectors & Industries:
-
May 14, 2024
Chinese Drug Co. Sanctioned After 'Tortuous' 3-Year Info Fight
Chinese drug firm Zhejiang Huahai Pharmaceutical Co. Ltd. has been hit with sanctions after its chief executive officer failed to sit for a court-ordered deposition in sprawling multidistrict litigation taking place in New Jersey over generic drugs that U.S. authorities say were contaminated with carcinogens.
-
February 08, 2023
Consumers And Insurers Get Class Cert. In Valsartan MDL
A New Jersey federal judge on Wednesday certified classes of consumers and insurers who claim they lost money by purchasing the contaminated blood pressure drug Valsartan, as well as two classes of consumers seeking medical monitoring for cancer potentially caused by the drug.
-
April 05, 2022
Valsartan MDL Judge OKs Out-Of-State Litigants, More Claims
A New Jersey federal judge ruled Tuesday that multidistrict litigation against drug manufacturers, pharmacies and wholesalers over carcinogens in blood pressure drugs can expand to include out-of-state litigants and warranty claims under laws in nearly two dozen jurisdictions.
-
December 22, 2021
Judge Overrules 'State Secrets' Concerns In Valsartan MDL
A New Jersey federal judge backed a special master's order that Zhejiang Huahai Pharmaceutical Co. Ltd. must produce documents it sought to shield in multidistrict litigation over blood pressure drugs such as valsartan, warning that parties can't exploit uncertainties in foreign state secrets laws to thwart U.S. lawsuits.
-
June 22, 2021
Chinese Drug Co. Chief Must Testify In Tainted Valsartan MDL
The special master in multidistrict litigation alleging that pharmaceutical companies sold generic drugs containing the active ingredient valsartan that were tainted with carcinogens ruled on Tuesday that the president of Zhejiang Huahai Pharmaceutical Co. Ltd. can't be blocked from giving a deposition in the case.
-
January 29, 2021
Drugmakers Must Face Fraud Claims In Valsartan MDL
A New Jersey federal judge said Friday he won't toss fraud claims against drug manufacturers, but will toss the claims against wholesalers and pharmacies, in multidistrict litigation alleging they took part in distributing generic drugs containing the active ingredient valsartan that were tainted with carcinogens.
-
January 25, 2021
Drugmakers Must Face Warranty Claims In Valsartan MDL
A New Jersey federal judge has said manufacturers, wholesalers and pharmacies cannot escape warranty claims in multidistrict litigation alleging they took part in distributing generic drugs containing the active ingredient valsartan that were tainted with carcinogens, finding that the drugs' names and the purported contamination kept certain claims alive.
-
January 12, 2021
Consumers Can't Bring Out-Of-State Claims in Valsartan MDL
A New Jersey federal judge said Tuesday that consumers in the multidistrict litigation over alleged contamination of the blood pressure drug valsartan don't have standing to bring claims under the laws of states they don't live in.
-
January 08, 2021
Drug. Co. Can't Keep Emails Under Wraps In Valsartan MDL
A New Jersey federal judge on Friday said that emails sent by Torrent Pharmaceuticals Ltd. to customers in the multidistrict litigation over alleged contamination of the blood pressure drug Valsartan are not confidential since they don't contain trade secrets.
-
January 04, 2021
Special Masters Tapped In Valsartan Contamination MDL
A New Jersey federal judge on Monday appointed two former federal judges as special masters to oversee settlement negotiations in multidistrict litigation over alleged contamination of the blood pressure drug Valsartan.